Eckert A

Neurobiology Laboratory for Brain Aging and Mental Health, Psychiatric University Hospital, University of Basel, Basel, Switzerland.

17 papers · ORCID

ArticleLSD

Acute and post-acute neurobehavioral responses to lysergic acid diethylamide in healthy subjects: a randomized controlled study.

Calder AE, Diehl VJ, Lietz MP +7

Europe PMC2026
ArticleMDMA

Comparison of acute effects of 3,4-methylenedioxymethamphetamine (MDMA) with and without a supplemental booster dose in healthy participants: a double-blind, randomized, placebo-controlled, crossover study.

Humbert-Droz M, Becker AM, Valenta J +6

Europe PMC2026
ArticlePsilocybin

Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants.

Arikci D, Borgulya J, Straumann I +8

Europe PMC2026
ArticleDMT

Dose-dependent pharmacokinetics and acute effects of intravenous bolus N,N-dimethyltryptamine: double-blind, randomized versus open-label dose-escalation administration study in healthy participants.

Erne L, Mueller L, Straumann I +7

Europe PMC2026
ArticleMDMA

Acute effects of MDMA, MDA, lysine-MDMA, and lysine-MDA in a randomized, double-blind, placebo-controlled, crossover trial in healthy participants.

Straumann I, Vizeli P, Avedisian I +7

Europe PMC2026
ArticleDMT

Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants.

Erne L, Vogt SB, Müller L +9

Europe PMC2025
ArticleMDMA

Acute effects of R-MDMA, S-MDMA, and racemic MDMA in a randomized double-blind cross-over trial in healthy participants.

Straumann I, Avedisian I, Klaiber A +5

Europe PMC2024
ArticleMDMA

Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants.

Straumann I, Ley L, Holze F +7

Europe PMC2023
ArticlePsilocybin

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.

Ley L, Holze F, Arikci D +11

Europe PMC2023
ArticleDMT

Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants.

Vogt SB, Ley L, Erne L +12

Europe PMC2023
ArticleLSD

Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants.

Becker AM, Klaiber A, Holze F +5

Europe PMC2023
ArticlePsilocybin

Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.

Holze F, Ley L, Müller F +10

Europe PMC2022
ArticlePsilocybin

Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects.

Becker AM, Holze F, Grandinetti T +8

Europe PMC2022
ArticleLSD

Role of the 5-HT<sub>2A</sub> Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin.

Holze F, Avedisian I, Varghese N +2

Europe PMC2021
ArticleLSD

Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects.

Holze F, Vizeli P, Ley L +8

Europe PMC2021
ArticleLSD

Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers.

Hutten NRPW, Mason NL, Dolder PC +8

Europe PMC2021
ArticleMDMA

Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects.

Holze F, Vizeli P, Müller F +6

Europe PMC2020